Patterns and Trends of Glucose‐Lowering Therapy in Alzheimer's Disease and Related Dementias

Documenti analoghi

• Cardiovascular and kidney outcomes of GLP ‐1 receptor agonists in adults with obesity: A target trial emulation study
  di: Huilin Tang, et al.
  Pubblicazione: (2025)
• Assessing the benefit–risk profile of newer glucose‐lowering drugs: A systematic review and network meta‐analysis of randomized outcome trials
  di: Huilin Tang, et al.
  Pubblicazione: (2024)
• Newer glucose‐lowering drugs and risk of suicidal ideation and behaviours: A network meta‐analysis of randomized outcome trials
  di: Ying Lu, et al.
  Pubblicazione: (2024)
• The 1‐Hour Plasma Glucose for Early Risk Stratification in Young, Obese Chinese Adults: Implications for Clinical Management
  di: Miaomiao Yuan, et al.
  Pubblicazione: (2026)
• Advances in Electrocardiogram‐Based Non‐Invasive Blood Glucose Monitoring Technology
  di: Qi Zeng, et al.
  Pubblicazione: (2026)